Stable Isotope Labelled Durvalumab Biosimilar – Anti-PD-L1 mAb – Research Grade

Reference: PX-TA1002-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Durvalumab Biosimilar - Anti-PD-L1 mAb - Research Grade
SourceDrugBank DB11714
SpeciesHuman
Expression systemMammalian cells
Molecular weight146kDa
Purity>95%
BufferPBS pH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsDurvalumab
ReferencePX-TA1002-SIL
Related ProductsPX-P3014
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year
FormulaC6502H10018N1742O2024S42

General information about Durvalumab

Recombinant monoclonal antibody to CD274. Durvalumab is a human monoclonal antibody that can be potentially used in the treatment of Cancers, non-small cell lung (NSCLC), Solid tumors, bladder, urothelial.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Durvalumab Biosimilar – Anti-PD-L1 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products